en-es
en-fr
en-sl
en
0.25
0.5
0.75
1.25
1.5
1.75
2
The track of cathepsins in diagnosis and therapy of cancer
Published on Dec 09, 2017728 Views
Decades ago lysosomal cysteine peptidases – the cathepsins, have been suggested as promotors of malignant processes. In collaboration with Tamara Lah we extensively evaluated their role in development
Related categories
Chapter list
The track of cathepsins in diagnosis and therapy of cancer – All that life!00:00
Cancer01:57
Cathepsin B 02:52
Cathepsin B - 103:51
Cysteine dependent proteolysis of ECM: intracellular and extracellular04:54
Cysteine dependent proteolysis of ECM: intracellular and extracellular - 105:42
Cathepsin B as prognostic marker for cancer patients06:11
Breast tumours (ELISA)07:11
Breast tumours (ELISA) - 107:40
Cathepsin B diagnosis and prognosis of brain tumors08:36
Inhibitors of CP: Prediction of prognosis09:18
CP inhibitors stefin A, stefin B and cystatin C in sera Prediction of prognosis09:52
CP inhibitors stefin A, stefin B and cystatin C in sera Prediction of prognosis - 110:03
Cathepsin X – back-up for cathepsin B in cancer10:37
Cathepsins’ inhibitors12:19
Specific delivery of small synthetic inhibitors to tumor cells12:53
Cystatin F as a mediator of cytotoxicity of NK and CTL13:15
Cancer Degradome14:13
1st Workshop on Experimental Cancer Biology14:31
1st Workshop on Experimental Cancer Biology - 115:06
Tamara, thank you and all the best15:55